Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients

NCT00013585 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

127

Enrollment

NIH

Sponsor class

Conditions

Cognition Disorders
HIV Infections

Interventions

DRUG: Selegiline hydrochloride

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]